Labshake search

1 - 50 of 1360 citations for Indusatumab Anti GUCY2C since 2020

• Interferons drive development of novel interleukin-15-responsive macrophages

  Scott M. Gordon, et al., bioRxiv - Immunology 2020

  Quote: ... Anti-IFNAR and anti-IFNGR (both BioXcell) were both used at 10μg/mL in culture.
• BET inhibition sensitizes immunologically-cold Rb-deficient prostate cancer to immune checkpoint blockade

  Brian Olson, et al., bioRxiv - Cancer Biology 2022

  Quote: ... anti-CD4 antibody and anti-CD8 antibodies (BioXCell, Lebanon ...
• Type 17 Follicular Helper T (Tfh17) Cells are Superior for Memory Maintenance

  Xin Gao, et al., bioRxiv - Immunology 2022

  Quote: ... anti-IFN-γ and anti-TGF-β (BioxCell) were used at 10 μg/mL ...
• Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4⁺ T cell-dependent manner

  Michael Brandon Ware, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
• Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets

  Defne Bayik, et al., bioRxiv - Immunology 2021

  Quote: ... anti-integrin β1 or anti-integrin β7 antibodies (BioXcell) for 1 hour on ice prior to transfer ...
• TGFβ Suppresses Type 2 Immunity to Cancer

  Ming Liu, et al., bioRxiv - Immunology 2020

  Quote: ... 100 μg anti-Csf1r or 500 μg anti-CD4 (BioXcell) were intraperitoneally injected into tumor-bearing mice twice a week ...
• A brain-body feedback loop driving HPA-axis dysfunction in breast cancer

  Adrian Gomez, et al., bioRxiv - Neuroscience 2024

  Quote: ... and Anti-CD8 (InVivoMAb anti-mouse CD8α, 100µg/mouse, BioXcell, #BE0061 ...
• Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling

  Nicholas C. DeVito, et al., bioRxiv - Cancer Biology 2024

  Quote: ... Anti-Ly6G (BioXCell) depletion antibody versus IgG isotype control was administered every other day at 200 mg/dose.
• Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment and confers resistance to immunotherapy

  Juan Yan, et al., bioRxiv - Cancer Biology 2022

  Quote: ... anti-CTLA4 and anti-2A3 were purchased from Bio X cell: Anti-mouse PD-1 (CD279 ...
• Therapeutic Tumor Macrophage Reprogramming in Breast Cancer Through a Peptide-Drug Conjugate

  Anni Lepland, et al., bioRxiv - Cancer Biology 2024

  Quote: ... MACTIDE-V+anti-PD-1 and anti-PD-1 groups received recombiMAb anti-mouse PD-1 (Bioxcell, Catalog #CP151), a mouse IgG2a monoclonal antibody with the D265A mutation in the Fc fragment which renders it unable to bind to endogenous Fcγ receptors ...
• An antibiotic that mediates immune destruction of senescent cancer cells

  Gabriele Casagrande Raffi, et al., bioRxiv - Cancer Biology 2024

  Quote: ... anti-CD8a (#2.43) and anti-NK1.1 (#PK-136) were purchased from BioXcell.
• IL-31 uncouples skin inflammation from itch sensation in allergic dermatitis

  Marlys S. Fassett, et al., bioRxiv - Immunology 2021

  Quote: ... anti-IFNγ (XMG1.2, BioXCell) and IL-4 (10,000 U/ml stock added as a supernatant from I3L6 cells(49)).
• Integrin αvβ8 on T cells is responsible for suppression of anti-tumor immunity in multiple syngeneic models and is a promising target for tumor immunotherapy

  Eswari Dodagatta-Marri, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CTLA4 (9D9 BioXcell) or isotype control E.tenella-mIgG2b 10mg/kg were injected on days 0 ...
• Transplantation Elicits a Clonally Diverse CD8⁺ T Cell Response that is Comprised of Potent CD43⁺ Effectors

  Gregory A. Cohen, et al., bioRxiv - Immunology 2022

  Quote: ... and anti-ICOS (BioXCell) via i.p ...
• Neuroblastoma formation requires unconventional CD4 T cells and myeloid amino acid metabolism

  Lee-Ann Van de Velde, et al., bioRxiv - Cancer Biology 2021

  Quote: ... and anti-B220 (BioXCell InVivoMab ...
• Intraluminal neutrophils limit epithelium damage by reducing pathogen assault on intestinal epithelial cells during Salmonella gut infection

  Ersin Gül, et al., bioRxiv - Immunology 2023

  Quote: ... anti-Ly6G (BioXCell, 1A8) was injected intraperitoneally at each day starting at pretreatment (In Fig.1 500µg/mouse ...
• Dendritic cell-mediated responses to secreted Cryptosporidium effectors are required for parasite-specific CD8⁺ T cell responses

  Breanne E. Haskins, et al., bioRxiv - Immunology 2023

  Quote: ... anti-horseradish peroxidase (BioXCell) prior to and after infection on various days ...
• De-glycosylated non-structural protein 1 enhances dengue virus clearance by limiting PD-L1/PD-1 mediated T cell apoptosis

  Fakhriedzwan Idris, et al., bioRxiv - Microbiology 2024

  Quote: ... Anti-CD8 antibody (BioXCell) or rat IgG2b isotype control (BioXCell ...
• Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma

  Chang Su, et al., bioRxiv - Cancer Biology 2024

  Quote: ... Anti-CD8 (BioXCell, BE0061) or isotype control (BioXCell ...
• Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19

  Harish Narasimhan, et al., bioRxiv - Immunology 2023

  Quote: ... anti-IFNγ (XMG1.2; BioXCell), anti-TNFα (XT3.11 ...
• Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19

  Harish Narasimhan, et al., bioRxiv - Immunology 2023

  Quote: ... anti-TNFα (XT3.11; BioXCell) or isotype control immunoglobulin G (IgG ...
• Increased multiplexity in optical tissue clearing-based 3D immunofluorescence microscopy of the tumor microenvironment by LED photobleaching

  Jingtian Zheng, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD8 (BioXcell, 2.43), anti-CD45 (BioLegend ...
• Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

  Na Zhao, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-PD1 (BioXCell # BE0146), and anti-CTLA-4 (BioXCell # BE0164 ...
• Increased multiplexity in optical tissue clearing-based 3D immunofluorescence microscopy of the tumor microenvironment by LED photobleaching

  Jingtian Zheng, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD3 (BioXcell, 17A2), and anti-CK8 (BioLegend ...
• INHBA/Activin A promotes tumor growth and induces resistance to anti-PD-L1 therapy by suppressing IFN-γ signaling

  Fanglin Li, et al., bioRxiv - Immunology 2023

  Quote: ... anti-CXCR3 (BE0249, BioXcell) and anti-IFN-γ (BE0055 ...
• Nasal tissue-resident memory CD4⁺ T cells persist after influenza A virus infection and provide heterosubtypic protection

  Nimitha R. Mathew, et al., bioRxiv - Immunology 2024

  Quote: ... anti-trinitrophenol (BE0089, Bioxcell) were used as controls.
• Potent antitumor activity of a designed interleukin-21 mimic

  Jung-Ho Chun, et al., bioRxiv - Biochemistry 2024

  Quote: ... anti-PD-1 (Bioxcell Cat# BE0146 ...
• CAR Treg synergy with anti-CD154 mediates infectious tolerance to dictate heart transplant outcomes

  Samarth S Durgam, et al., bioRxiv - Immunology 2024

  Quote: ... Anti-CD154 (MR1, BioXCell) was injected i.v on the day of HTx at the indicated doses ...
• Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treat low-burden metastases

  Shih-Wen Huang, et al., bioRxiv - Immunology 2024

  Quote: ... anti-CD8α (2.43, BioXcell), or both antibodies 19 days after EO771 inoculation ...
• Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy

  Zhihua Kang, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and Vehicle+anti-PD-1 and UNC0642+anti-PD-1 mice were treated with 200 μg anti-PD-1 (BioXCell, BE0273) via intraperitoneal (i.p. ...
• The Injury Response to DNA Damage Promotes Anti-Tumor Immunity

  Ganapathy Sriram, et al., bioRxiv - Cancer Biology 2020

  Quote: ... Anti-PD1 (clone RMP1-14) and anti-CTLA4 (clone 9D9) were from BioXcell. Anti-Batf3 antibody was purchased from Abcam (#ab211304).
• Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer

  Wei Yan, et al., bioRxiv - Cancer Biology 2023

  Quote: ... Anti-PD1 treatment: Purified anti-mPD-1 antibody (BioXcell #BE0033-2; clone J43) was used for in vivo PD-1 blockade at a dosage of 200 μg/mouse through i.p ...
• Arkadia-SKI/SnoN signaling cascade differentially regulates TGF-β-induced iTreg and Th17 cell differentiation

  Hao Xu, et al., bioRxiv - Immunology 2021

  Quote: ... 2 µg/mL anti-IL-4 and anti-IFNγ antibody (BioXcell, Clone: XMG 1.2). 10 µM SB525334 was used to replace TGF-β to inhibit TGF-β signaling if required ...
• Gasdermin-D-dependent IL-1α release from microglia promotes protective immunity during chronic Toxoplasma gondii infection

  Samantha J. Batista, et al., bioRxiv - Immunology 2020

  Quote: ... each of anti-LFA-1 and anti-VLA-4 blocking antibodies (Bio X Cell) or control IgG ...
• TNF Superfamily Member 14 Drives Post-Influenza Depletion of Alveolar Macrophages Enabling Secondary Pneumococcal Pneumonia

  Christina Malainou, et al., bioRxiv - Molecular Biology 2024

  Quote: ... application of 200µg anti-1A8 antibody (InVivoPlus anti-mouse Ly6G, Cat BP0075-1, BioXCell) or an anti-2A3 isotype control (InVivoPlusTM rat IgG2a isotype control ...
• PD-1 checkpoint blockade disrupts CD4 T cell regulated adaptive B cell tolerance to foreign antigens

  Chad R. Dufaud, et al., bioRxiv - Immunology 2021

  Quote: ... anti-trinitrophenol (clone 2A3, BioXcell). For CD4 depletion ...
• PSGL-1 directs early TCR signaling to repress metabolism and promote T cell exhaustion by modulating the TCF-1/TOX axis in CD8⁺ T cells

  Jennifer L. Hope, et al., bioRxiv - Immunology 2022

  Quote: ... anti-PSGL-1 (4RA10, BioXcell), or both for 15 minutes at 4°C ...
• PSGL-1 directs early TCR signaling to repress metabolism and promote T cell exhaustion by modulating the TCF-1/TOX axis in CD8⁺ T cells

  Jennifer L. Hope, et al., bioRxiv - Immunology 2022

  Quote: ... and anti-CD28 (37.51, BioXcell)(5 μg/mL ...
• IL-31 uncouples skin inflammation from itch sensation in allergic dermatitis

  Marlys S. Fassett, et al., bioRxiv - Immunology 2021

  Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
• Superantigens promote Staphylococcus aureus bloodstream infection by eliciting pathogenic interferon-gamma (IFNγ) production that subverts macrophage function

  Stephen W. Tuffs, et al., bioRxiv - Microbiology 2021

  Quote: ... anti-CD8 (clone YTS169.4, BioXCell); or both ...
• Superantigens promote Staphylococcus aureus bloodstream infection by eliciting pathogenic interferon-gamma (IFNγ) production that subverts macrophage function

  Stephen W. Tuffs, et al., bioRxiv - Microbiology 2021

  Quote: ... anti-IFNγ (clone XMG1.2, BioXCell) or Rat IgG1 isotype control ...
• Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by sequential intermittent anti-PI3Kα/β/δ and anti-PD-1 treatment

  Zhi Qi, et al., bioRxiv - Cancer Biology 2020

  Quote: ... Anti-PD-1 (BioXcell, BE0146) or isotype control (BioXcell ...
• Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron

  Zhenlu Chong, et al., bioRxiv - Microbiology 2022

  Quote: ... anti-Ly6G (BioXCell; clone 1A8) or an isotype control (BioXCell ...
• Induction of senescence renders cancer cells highly immunogenic

  Inés Marín, et al., bioRxiv - Cancer Biology 2022

  Quote: ... anti-CD8 (clone 2.43, BioxCell), anti-CD11b (clone M1/70 ...
• Tumor-educated Gr1⁺CD11b⁺ cells instigate breast cancer metastasis by twisting cancer cells plasticity via OSM/IL6–JAK signaling

  Sanam Peyvandi, et al., bioRxiv - Cancer Biology 2022

  Quote: ... anti-mouse IL-6 (BioxCell), recombinant mouse Oncostatin M and IL-6 (Biolegend ...
• Activating a collaborative innate-adaptive immune response to control breast and ovarian cancer metastasis

  Lijuan Sun, et al., bioRxiv - Cancer Biology 2020

  Quote: Anti-CD8 (#BE0004-1, BioXCell) and anti-CD4 (#BE0003-1 ...
• Targeting macrophages with CAR-T cells delays solid tumor progression and enhances anti-tumor immunity

  Alfonso R. Sánchez-Paulete, et al., bioRxiv - Immunology 2021

  Quote: ... Anti-PD1 (RMP1-14, BioXCell) was diluted in PBS to a concentration of 1 mg/ml for intraperitoneal administration of 100 ug ...
• KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance

  Anastasia-Maria Zavitsanou, et al., bioRxiv - Cancer Biology 2021

  Quote: ... anti-PD1 (29F.1A12, Bioxcell), anti-PD-L1 (10F.9G2 ...
• KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance

  Anastasia-Maria Zavitsanou, et al., bioRxiv - Cancer Biology 2021

  Quote: ... anti-PD1 (29F.1A12, Bioxcell) was used ...
• KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance

  Anastasia-Maria Zavitsanou, et al., bioRxiv - Cancer Biology 2021

  Quote: ... and anti-CD4 (GK1.5, Bioxcell) were used ...